Trial intelligence / Profile preview

Chlorhexidine Gluconate for Healing Grade IIB Diabetic Foot Ulcers

NCT03209466Phase 4Unknown

Sponsor
Universidad de Guanajuato
Start
May 2017
Primary completion
Dec 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, triple-blind trial in diabetic foot ulcer (DFU) comparing Chlorhexidine Gluconate with Placebo (Saline) (2 arms). Primary endpoint: Ulcerated area at 6 weeks. Status: unknown.

02

Drugs

chlorhexidine
03

Conditions

diabetic foot ulcer (DFU)

Beyond the preview

Go deeper on NCT03209466.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03209466.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call